Quarterly report pursuant to Section 13 or 15(d)

Restatement (Tables)

v3.20.2
Restatement (Tables)
3 Months Ended
Mar. 31, 2020
Restatementof Previously Issued Condensed Consolidated Interim Financial Statements [Abstract]  
Schedule of previously reported condensed consolidated balance sheet
    March 31, 2020  
    As Reported     Adjustment     As Restated  
Convertible notes payable, net   $ 565,781     $ (159,299 )   $ 406,482  
Derivative liabilities   $ -     $ 571,843     $ 571,843  
Current liabilities   $ 1,467,171     $ 412,544     $ 1,879,715  
Total liabilities   $ 1,467,171     $ 412,544     $ 1,879,715  
Accumulated deficit   $ (4,211,193 )   $ (412,544 )   $ (4,623,737 )
Total stockholders’ deficit   $ 1,419,785     $ (412,544 )   $ (1,832,329 )
Schedule of previously condensed consolidated statement of operations and comprehensive loss
    March 31, 2020  
    As Reported     Adjustment     As Restated  
Interest expense   $ (88,291 )   $ (365,325 )   $ (453,616 )
Change in fair market value of derivative liabilities   $ -     $ (47,219 )   $ (47,219 )
Net Loss   $ (539,116 )   $ (412,544 )   $ (951,660 )
Total comprehensive loss   $ (540,169 )   $ (412,544 )   $ (952,713 )
Net loss per common share, basic and diluted   $ (0.03 )   $ (0.02 )   $ (0.05 )